The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome

被引:8
|
作者
Kurose, Nozomu [1 ]
Guo, Xin [1 ]
Shioya, Akihiro [1 ]
Mizutani, Ken-ichi [1 ]
Kumagai, Motona [1 ]
Fujimoto, Shino [2 ]
Kawabata, Hiroshi [2 ]
Masaki, Yasufumi [2 ]
Takai, Kazue [3 ]
Aoki, Sadao [4 ]
Nakamura, Shigeo [5 ]
Yamada, Sohsuke [1 ]
机构
[1] Dept Pathol & Lab Med, Uchinada, Ishikawa, Japan
[2] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa, Japan
[3] Niigata City Gen Hosp, Div Hematol, Niigata, Japan
[4] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Pathophysiol, Niigata, Japan
[5] Nagoya Univ, Dept Pathol & Biol Response, Grad Sch Med, Nagoya, Aichi, Japan
关键词
TAFRO syndrome; Follicular helper T cell; IgG4-related disease; CXCR5; CD40L; DIFFERENTIATION; EXPRESSION; PATHOGENESIS;
D O I
10.1016/j.prp.2019.152563
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Idiopathic multicentric Castleman disease (iMCD) is a systemic inflammatory disease of unknown etiology caused by hypercytokinemia. Recently, TAFRO (thrombocytopenia, gnasarca, fever, renal failure or reticulin fibrosis, and organomegaly) syndrome has been reported, which shows similar histopathological findings to iMCD and factors associated with a poor prognosis. IMCD shows no plasma cell infiltration in the germinal center (GC), but CD38-positive (CD38(+))-plasma cells are observed in the interfollicular area. Our previous report revealed that atrophic change of GC, glomeruloid vascular proliferation, and abnormal proliferation of follicular dendritic cells are more prominent in iMCD with TAFRO (TAFRO +) in comparison to iMCD without TAFRO (TAFRO ). In addition, the numbers of CD38(+) and immunoglobulin G4-positive (IgG4(+)) plasma cells were decreased in the interfollicular area. The roles of T follicular helper cells (Tfh) are well-known to assist B-cell proliferation, maturation, and differentiation . It maintains the formation of GC and is also related in the class switching of IgG isotypes, including IgG4. Thus, we immunohistochemically examined the number of Tfh in GCs in both TAFRO(-) and TAFRO(+) iMCD. The number of Tfh was significantly decreased in TAFRO(-) iMCD (n = 9) and was further decreased in TAFRO(+) iMCD (n = 18) in comparison to non-specific lymphadenopathy (n = 6) and IgG4-related disease (n = 4). These results suggest that decreased Tfh may be one etiology of iMCD.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy
    Williams, Corinne
    Phillips, Alexis
    Aggarwal, Vikram
    Slonim, Liron Barnea
    Fajgenbaum, David C.
    Karmali, Reem
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1359 - 1365
  • [22] Idiopathic multicentric Castleman disease-TAFRO after COVID-19: A case report
    Shiina, Tatsuro
    Yamamoto, Eriko Kashihara
    Yamada, Hirotaka
    Sendo, Sho
    Kanzawa, Maki
    Saegusa, Jun
    MODERN RHEUMATOLOGY CASE REPORTS, 2024,
  • [23] Tafro Syndrome without Pathological Evidence Consistent with Castleman Disease: A Subtype of Tafro or a Distinct Disease Entity?
    Li, Siyuan
    Gao, Yuhan
    Dang, Yue
    Zhang, Lu
    Li, Jian
    BLOOD, 2024, 144 : 6298 - 6299
  • [24] The role of the T follicular helper cells in allergic disease
    DM Kemeny
    Cellular & Molecular Immunology, 2012, 9 : 386 - 389
  • [25] The role of the T follicular helper cells in allergic disease
    Kemeny, D. M.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2012, 9 (05) : 386 - 389
  • [26] CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease
    Kiguchi, T.
    Sato, C.
    Takai, K.
    Nakai, Y.
    Kaneko, Y.
    Matsuki, M.
    CLINICAL RADIOLOGY, 2017, 72 (10) : 905.e1 - 905.e5
  • [27] Serum Soluble Interleukin-2 Receptor as a Potential Marker for Assessing Disease Activity in the TAFRO Subtype of Idiopathic Multicentric Castleman Disease
    Ozaki, Takashi
    Imada, Chiharu
    Shirakami, Kohei
    Abe, Tasuku
    Shingai, Yuta
    Umeki, Tatsuhito
    Fukuda, Akihiro
    Ishii, Koji
    Shibata, Hirotaka
    INTERNAL MEDICINE, 2025,
  • [28] Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome)
    Kageyama, Chihiro
    Igawa, Takuro
    Gion, Yuka
    Iwaki, Noriko
    Tabata, Tetsuya
    Tanaka, Takehiro
    Kondo, Eisei
    Sakai, Hajime
    Tsuneyama, Koichi
    Nomoto, Kazuhiro
    Noguchi, Hiroko
    Yoshino, Tadashi
    Yokota, Kenji
    Sato, Yasuharu
    PATHOLOGY INTERNATIONAL, 2019, 69 (10) : 572 - 579
  • [29] VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman disease
    Philipa, Remi
    Cadro, Vincent
    Aouba, Achille
    Chantepie, Sylvain
    Bracquemart, Claire
    Dumonta, Anael
    JOINT BONE SPINE, 2024, 91 (04)
  • [30] The potential role of follicular helper T cells and helper T cells type 1 in Warthin tumour
    Kobayashi, Yoshiaki
    Kurose, Nozomu
    Guo, Xin
    Shioya, Akihiro
    Kitamura, Morimasa
    Tsuji, Hiroyuki
    Yamada, Sohsuke
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 220